Granulocyte-macrophage colony-stimulating factor to increase efficacy of mitoxantrone, etoposide and cytarabine in previously untreated elderly patients with acute myeloid leukaemia: a Swedish multicentre randomized trial. [electronic resource]
Producer: 20040504Description: 474-80 p. digitalISSN:- 0007-1048
- Acute Disease
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cytarabine -- administration & dosage
- Etoposide -- administration & dosage
- Female
- Granulocyte-Macrophage Colony-Stimulating Factor -- therapeutic use
- Humans
- Leukemia, Myeloid -- drug therapy
- Male
- Middle Aged
- Mitoxantrone -- administration & dosage
- Neutropenia -- chemically induced
- Opportunistic Infections -- prevention & control
- Remission Induction
- Survival Analysis
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.